Apricus Biosciences, Inc., a biopharmaceutical company, is advancing innovative medicines in urology and rheumatology. The company’s lead product, Vitaros, used for the treatment of erectile dysfunction, is approved in Europe and Canada and commercialized in several countries in Europe. The company’s second-generation Vitaros room temperature device is under development and is expected to enhance the product’s commercial value. For more information, visit the company’s website at www.apricusbio.com.